Global Oral Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 166180
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Oral Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oral Vaccines size is estimated to be xx million in 2021 from USD 2573.9 million in 2020, with a change of XX% between 2020 and 2021. The global Oral Vaccines market size is expected to grow at a CAGR of 6.8% for the next five years.

Market segmentation

Oral Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Others

Market segment by Application can be divided into

Public

Private

The key market players for global Oral Vaccines market are listed below:

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Oral Vaccines product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Oral Vaccines, with price, sales, revenue and global market share of Oral Vaccines in 2018 and 2019.

Chapter 3, the Oral Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Oral Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oral Vaccines market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Oral Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Oral Vaccines Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Oral Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Rotavirus Vaccine

1.2.3 Cholera Vaccine

1.2.4 Oral Polio Vaccine

1.2.5 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Oral Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Public

1.3.3 Private

1.4 Global Oral Vaccines Market Size & Forecast

1.4.1 Global Oral Vaccines Sales in Value (2016-2026))

1.4.2 Global Oral Vaccines Sales in Volume (2016-2026)

1.4.3 Global Oral Vaccines Price by Type (2016-2026) & (USD/K Doses)

1.5 Global Oral Vaccines Production Capacity Analysis

1.5.1 Global Oral Vaccines Total Production Capacity (2016-2026)

1.5.2 Global Oral Vaccines Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Oral Vaccines Market Drivers

1.6.2 Oral Vaccines Market Restraints

1.6.3 Oral Vaccines Trends Analysis

2 Manufacturers Profiles

2.1 Merck

2.1.1 Merck Details

2.1.2 Merck Major Business

2.1.3 Merck Oral Vaccines Product and Services

2.1.4 Merck Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 GSK

2.2.1 GSK Details

2.2.2 GSK Major Business

2.2.3 GSK Oral Vaccines Product and Services

2.2.4 GSK Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi Oral Vaccines Product and Services

2.3.4 Sanofi Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Lanzhou Institute

2.4.1 Lanzhou Institute Details

2.4.2 Lanzhou Institute Major Business

2.4.3 Lanzhou Institute Oral Vaccines Product and Services

2.4.4 Lanzhou Institute Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Serum Institute

2.5.1 Serum Institute Details

2.5.2 Serum Institute Major Business

2.5.3 Serum Institute Oral Vaccines Product and Services

2.5.4 Serum Institute Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Valneva

2.6.1 Valneva Details

2.6.2 Valneva Major Business

2.6.3 Valneva Oral Vaccines Product and Services

2.6.4 Valneva Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Shanghai United Cell

2.7.1 Shanghai United Cell Details

2.7.2 Shanghai United Cell Major Business

2.7.3 Shanghai United Cell Oral Vaccines Product and Services

2.7.4 Shanghai United Cell Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Bibcol

2.8.1 Bibcol Details

2.8.2 Bibcol Major Business

2.8.3 Bibcol Oral Vaccines Product and Services

2.8.4 Bibcol Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 PaxVax

2.9.1 PaxVax Details

2.9.2 PaxVax Major Business

2.9.3 PaxVax Oral Vaccines Product and Services

2.9.4 PaxVax Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Vabiotech

2.10.1 Vabiotech Details

2.10.2 Vabiotech Major Business

2.10.3 Vabiotech Oral Vaccines Product and Services

2.10.4 Vabiotech Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Tiantan Biological

2.11.1 Tiantan Biological Details

2.11.2 Tiantan Biological Major Business

2.11.3 Tiantan Biological Oral Vaccines Product and Services

2.11.4 Tiantan Biological Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 EuBiologics

2.12.1 EuBiologics Details

2.12.2 EuBiologics Major Business

2.12.3 EuBiologics Oral Vaccines Product and Services

2.12.4 EuBiologics Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Panacea Biotec Ltd

2.13.1 Panacea Biotec Ltd Details

2.13.2 Panacea Biotec Ltd Major Business

2.13.3 Panacea Biotec Ltd Oral Vaccines Product and Services

2.13.4 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Bio-Med

2.14.1 Bio-Med Details

2.14.2 Bio-Med Major Business

2.14.3 Bio-Med Oral Vaccines Product and Services

2.14.4 Bio-Med Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 Halfkin Bio-Pharmaceuticals

2.15.1 Halfkin Bio-Pharmaceuticals Details

2.15.2 Halfkin Bio-Pharmaceuticals Major Business

2.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services

2.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Oral Vaccines Sales by Manufacturer

3.1 Global Oral Vaccines Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Oral Vaccines Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Oral Vaccines

3.4 Market Concentration Rate

3.4.1 Top 3 Oral Vaccines Manufacturer Market Share

3.4.2 Top 6 Oral Vaccines Manufacturer Market Share

3.5 Global Oral Vaccines Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Oral Vaccines Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Oral Vaccines Market Size by Region

4.1.1 Global Oral Vaccines Sales in Volume by Region (2016-2026)

4.1.2 Global Oral Vaccines Revenue by Region (2016-2026)

4.2 North America Oral Vaccines Revenue (2016-2026)

4.3 Europe Oral Vaccines Revenue (2016-2026)

4.4 Asia-Pacific Oral Vaccines Revenue (2016-2026)

4.5 South America Oral Vaccines Revenue (2016-2026)

4.6 Middle East and Africa Oral Vaccines Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Oral Vaccines Sales in Volume by Type (2016-2026)

5.2 Global Oral Vaccines Revenue by Type (2016-2026)

5.3 Global Oral Vaccines Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Oral Vaccines Sales in Volume by Application (2016-2026)

6.2 Global Oral Vaccines Revenue by Application (2016-2026)

6.3 Global Oral Vaccines Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Oral Vaccines Sales by Type (2016-2026)

7.2 North America Oral Vaccines Sales by Application (2016-2026)

7.3 North America Oral Vaccines Market Size by Country

7.3.1 North America Oral Vaccines Sales in Volume by Country (2016-2026)

7.3.2 North America Oral Vaccines Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Oral Vaccines Sales by Type (2016-2026)

8.2 Europe Oral Vaccines Sales by Application (2016-2026)

8.3 Europe Oral Vaccines Market Size by Country

8.3.1 Europe Oral Vaccines Sales in Volume by Country (2016-2026)

8.3.2 Europe Oral Vaccines Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Oral Vaccines Sales by Type (2016-2026)

9.2 Asia-Pacific Oral Vaccines Sales by Application (2016-2026)

9.3 Asia-Pacific Oral Vaccines Market Size by Region

9.3.1 Asia-Pacific Oral Vaccines Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Oral Vaccines Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Oral Vaccines Sales by Type (2016-2026)

10.2 South America Oral Vaccines Sales by Application (2016-2026)

10.3 South America Oral Vaccines Market Size by Country

10.3.1 South America Oral Vaccines Sales in Volume by Country (2016-2026)

10.3.2 South America Oral Vaccines Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Oral Vaccines Sales by Type (2016-2026)

11.2 Middle East & Africa Oral Vaccines Sales by Application (2016-2026)

11.3 Middle East & Africa Oral Vaccines Market Size by Country

11.3.1 Middle East & Africa Oral Vaccines Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Oral Vaccines Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Oral Vaccines Typical Distributors

12.3 Oral Vaccines Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Oral Vaccines Revenue by Type, (USD Million), 2021-2026

Table 2. Global Oral Vaccines Revenue by Application, (USD Million), 2021-2026

Table 3. Merck Basic Information, Manufacturing Base and Competitors

Table 4. Merck Major Business

Table 5. Merck Oral Vaccines Product and Services

Table 6. Merck Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. GSK Basic Information, Manufacturing Base and Competitors

Table 8. GSK Major Business

Table 9. GSK Oral Vaccines Product and Services

Table 10. GSK Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Sanofi Basic Information, Manufacturing Base and Competitors

Table 12. Sanofi Major Business

Table 13. Sanofi Oral Vaccines Product and Services

Table 14. Sanofi Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Lanzhou Institute Basic Information, Manufacturing Base and Competitors

Table 16. Lanzhou Institute Major Business

Table 17. Lanzhou Institute Oral Vaccines Product and Services

Table 18. Lanzhou Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Serum Institute Basic Information, Manufacturing Base and Competitors

Table 20. Serum Institute Major Business

Table 21. Serum Institute Oral Vaccines Product and Services

Table 22. Serum Institute Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Valneva Basic Information, Manufacturing Base and Competitors

Table 24. Valneva Major Business

Table 25. Valneva Oral Vaccines Product and Services

Table 26. Valneva Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Shanghai United Cell Basic Information, Manufacturing Base and Competitors

Table 28. Shanghai United Cell Major Business

Table 29. Shanghai United Cell Oral Vaccines Product and Services

Table 30. Shanghai United Cell Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Bibcol Basic Information, Manufacturing Base and Competitors

Table 32. Bibcol Major Business

Table 33. Bibcol Oral Vaccines Product and Services

Table 34. Bibcol Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. PaxVax Basic Information, Manufacturing Base and Competitors

Table 36. PaxVax Major Business

Table 37. PaxVax Oral Vaccines Product and Services

Table 38. PaxVax Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Vabiotech Basic Information, Manufacturing Base and Competitors

Table 40. Vabiotech Major Business

Table 41. Vabiotech Oral Vaccines Product and Services

Table 42. Vabiotech Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Tiantan Biological Basic Information, Manufacturing Base and Competitors

Table 44. Tiantan Biological Major Business

Table 45. Tiantan Biological Oral Vaccines Product and Services

Table 46. Tiantan Biological Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. EuBiologics Basic Information, Manufacturing Base and Competitors

Table 48. EuBiologics Major Business

Table 49. EuBiologics Oral Vaccines Product and Services

Table 50. EuBiologics Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors

Table 52. Panacea Biotec Ltd Major Business

Table 53. Panacea Biotec Ltd Oral Vaccines Product and Services

Table 54. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Bio-Med Basic Information, Manufacturing Base and Competitors

Table 56. Bio-Med Major Business

Table 57. Bio-Med Oral Vaccines Product and Services

Table 58. Bio-Med Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 60. Halfkin Bio-Pharmaceuticals Major Business

Table 61. Halfkin Bio-Pharmaceuticals Oral Vaccines Product and Services

Table 62. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Global Oral Vaccines Sales by Manufacturer (2019-2021e) & (M Doses)

Table 64. Global Oral Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 65. Market Position of Manufacturers in Oral Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 66. Global Oral Vaccines Production Capacity by Company, (M Doses): 2020 VS 2021

Table 67. Head Office and Oral Vaccines Production Site of Key Manufacturer

Table 68. Oral Vaccines New Entrant and Capacity Expansion Plans

Table 69. Oral Vaccines Mergers & Acquisitions in the Past Five Years

Table 70. Global Oral Vaccines Sales by Region (2016-2021e) & (M Doses)

Table 71. Global Oral Vaccines Sales by Region (2021-2026) & (M Doses)

Table 72. Global Oral Vaccines Revenue by Region (2016-2021e) & (USD Million)

Table 73. Global Oral Vaccines Revenue by Region (2021-2026) & (USD Million)

Table 74. Global Oral Vaccines Sales by Type (2016-2021e) & (M Doses)

Table 75. Global Oral Vaccines Sales by Type (2021-2026) & (M Doses)

Table 76. Global Oral Vaccines Revenue by Type (2016-2021e) & (USD Million)

Table 77. Global Oral Vaccines Revenue by Type (2021-2026) & (USD Million)

Table 78. Global Oral Vaccines Price by Type (2016-2021e) & (USD/K Doses)

Table 79. Global Oral Vaccines Price by Type (2021-2026) & (USD/K Doses)

Table 80. Global Oral Vaccines Sales by Application (2016-2021e) & (M Doses)

Table 81. Global Oral Vaccines Sales by Application (2021-2026) & (M Doses)

Table 82. Global Oral Vaccines Revenue by Application (2016-2021e) & (USD Million)

Table 83. Global Oral Vaccines Revenue by Application (2021-2026) & (USD Million)

Table 84. Global Oral Vaccines Price by Application (2016-2021e) & (USD/K Doses)

Table 85. Global Oral Vaccines Price by Application (2021-2026) & (USD/K Doses)

Table 86. North America Oral Vaccines Sales by Country (2016-2021e) & (M Doses)

Table 87. North America Oral Vaccines Sales by Country (2021-2026) & (M Doses)

Table 88. North America Oral Vaccines Revenue by Country (2016-2021e) & (USD Million)

Table 89. North America Oral Vaccines Revenue by Country (2021-2026) & (USD Million)

Table 90. North America Oral Vaccines Sales by Type (2016-2021e) & (M Doses)

Table 91. North America Oral Vaccines Sales by Type (2021-2026) & (M Doses)

Table 92. North America Oral Vaccines Sales by Application (2016-2021e) & (M Doses)

Table 93. North America Oral Vaccines Sales by Application (2021-2026) & (M Doses)

Table 94. Europe Oral Vaccines Sales by Country (2016-2021e) & (M Doses)

Table 95. Europe Oral Vaccines Sales by Country (2021-2026) & (M Doses)

Table 96. Europe Oral Vaccines Revenue by Country (2016-2021e) & (USD Million)

Table 97. Europe Oral Vaccines Revenue by Country (2021-2026) & (USD Million)

Table 98. Europe Oral Vaccines Sales by Type (2016-2021e) & (M Doses)

Table 99. Europe Oral Vaccines Sales by Type (2021-2026) & (M Doses)

Table 100. Europe Oral Vaccines Sales by Application (2016-2021e) & (M Doses)

Table 101. Europe Oral Vaccines Sales by Application (2021-2026) & (M Doses)

Table 102. Asia-Pacific Oral Vaccines Sales by Region (2016-2021e) & (M Doses)

Table 103. Asia-Pacific Oral Vaccines Sales by Region (2021-2026) & (M Doses)

Table 104. Asia-Pacific Oral Vaccines Revenue by Region (2016-2021e) & (USD Million)

Table 105. Asia-Pacific Oral Vaccines Revenue by Region (2021-2026) & (USD Million)

Table 106. Asia-Pacific Oral Vaccines Sales by Type (2016-2021e) & (M Doses)

Table 107. Asia-Pacific Oral Vaccines Sales by Type (2021-2026) & (M Doses)

Table 108. Asia-Pacific Oral Vaccines Sales by Application (2016-2021e) & (M Doses)

Table 109. Asia-Pacific Oral Vaccines Sales by Application (2021-2026) & (M Doses)

Table 110. South America Oral Vaccines Sales by Country (2016-2021e) & (M Doses)

Table 111. South America Oral Vaccines Sales by Country (2021-2026) & (M Doses)

Table 112. South America Oral Vaccines Revenue by Country (2016-2021e) & (USD Million)

Table 113. South America Oral Vaccines Revenue by Country (2021-2026) & (USD Million)

Table 114. South America Oral Vaccines Sales by Type (2016-2021e) & (M Doses)

Table 115. South America Oral Vaccines Sales by Type (2021-2026) & (M Doses)

Table 116. South America Oral Vaccines Sales by Application (2016-2021e) & (M Doses)

Table 117. South America Oral Vaccines Sales by Application (2021-2026) & (M Doses)

Table 118. Middle East & Africa Oral Vaccines Sales by Country (2016-2021e) & (M Doses)

Table 119. Middle East & Africa Oral Vaccines Sales by Country (2021-2026) & (M Doses)

Table 120. Middle East & Africa Oral Vaccines Revenue by Country (2016-2021e) & (USD Million)

Table 121. Middle East & Africa Oral Vaccines Revenue by Country (2021-2026) & (USD Million)

Table 122. Middle East & Africa Oral Vaccines Sales by Type (2016-2021e) & (M Doses)

Table 123. Middle East & Africa Oral Vaccines Sales by Type (2021-2026) & (M Doses)

Table 124. Middle East & Africa Oral Vaccines Sales by Application (2016-2021e) & (M Doses)

Table 125. Middle East & Africa Oral Vaccines Sales by Application (2021-2026) & (M Doses)

Table 126. Direct Channel Pros & Cons

Table 127. Indirect Channel Pros & Cons

Table 128. Oral Vaccines Typical Distributors

Table 129. Oral Vaccines Typical Customers

List of Figures

Figure 1. Oral Vaccines Picture

Figure 2. Global Oral Vaccines Sales Market Share by Type in 2020

Figure 3. Rotavirus Vaccine

Figure 4. Cholera Vaccine

Figure 5. Oral Polio Vaccine

Figure 6. Others

Figure 7. Global Oral Vaccines Sales Market Share by Application in 2020

Figure 8. Public

Figure 9. Private

Figure 10. Global Oral Vaccines Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026

Figure 11. Global Oral Vaccines Market Size and Forecast (2016-2026) & (USD Million)

Figure 12. Global Oral Vaccines Sales (2016-2026) & (M Doses)

Figure 13. Global Oral Vaccines Price by Type (2016-2026) & (USD/K Doses)

Figure 14. Global Oral Vaccines Production Capacity (2016-2026) & (M Doses)

Figure 15. Global Oral Vaccines Production Capacity by Geographic Region: 2020 VS 2021

Figure 16. Oral Vaccines Market Drivers

Figure 17. Oral Vaccines Market Restraints

Figure 18. Oral Vaccines Market Trends

Figure 19. Global Oral Vaccines Sales Market Share by Manufacturer in 2020

Figure 20. Global Oral Vaccines Revenue Market Share by Manufacturer in 2020

Figure 21. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. Top 3 Oral Vaccines Manufacturer (Revenue) Market Share in 2020

Figure 23. Top 6 Oral Vaccines Manufacturer (Revenue) Market Share in 2020

Figure 24. Global Oral Vaccines Sales Market Share by Region (2016-2026)

Figure 25. Global Oral Vaccines Revenue Market Share by Region (2016-2026)

Figure 26. North America Oral Vaccines Revenue (2016-2026) & (USD Million)

Figure 27. Europe Oral Vaccines Revenue (2016-2026) & (USD Million)

Figure 28. Asia-Pacific Oral Vaccines Revenue (2016-2026) & (USD Million)

Figure 29. South America Oral Vaccines Revenue (2016-2026) & (USD Million)

Figure 30. Middle East & Africa Oral Vaccines Revenue (2016-2026) & (USD Million)

Figure 31. Global Oral Vaccines Sales Market Share by Type (2016-2026)

Figure 32. Global Oral Vaccines Revenue Market Share by Type (2016-2026)

Figure 33. Global Oral Vaccines Price by Type (2016-2026) & (USD/K Doses)

Figure 34. Global Oral Vaccines Sales Market Share by Application (2016-2026)

Figure 35. Global Oral Vaccines Revenue Market Share by Application (2016-2026)

Figure 36. Global Oral Vaccines Price by Application (2016-2026) & (USD/K Doses)

Figure 37. North America Oral Vaccines Sales Market Share by Type (2016-2026)

Figure 38. North America Oral Vaccines Sales Market Share by Application (2016-2026)

Figure 39. North America Oral Vaccines Sales Market Share by Country (2016-2026)

Figure 40. North America Oral Vaccines Revenue Market Share by Country (2016-2026)

Figure 41. United States Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Oral Vaccines Sales Market Share by Type (2016-2026)

Figure 45. Europe Oral Vaccines Sales Market Share by Application (2016-2026)

Figure 46. Europe Oral Vaccines Sales Market Share by Country (2016-2026)

Figure 47. Europe Oral Vaccines Revenue Market Share by Country (2016-2026)

Figure 48. Germany Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Oral Vaccines Sales Market Share by Region (2016-2026)

Figure 54. Asia-Pacific Oral Vaccines Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Oral Vaccines Sales Market Share by Region (2016-2026)

Figure 56. Asia-Pacific Oral Vaccines Revenue Market Share by Region (2016-2026)

Figure 57. China Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Korea Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Oral Vaccines Sales Market Share by Type (2016-2026)

Figure 64. South America Oral Vaccines Sales Market Share by Application (2016-2026)

Figure 65. South America Oral Vaccines Sales Market Share by Country (2016-2026)

Figure 66. South America Oral Vaccines Revenue Market Share by Country (2016-2026)

Figure 67. Brazil Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Argentina Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Middle East & Africa Oral Vaccines Sales Market Share by Type (2016-2026)

Figure 70. Middle East & Africa Oral Vaccines Sales Market Share by Application (2016-2026)

Figure 71. Middle East & Africa Oral Vaccines Sales Market Share by Country (2016-2026)

Figure 72. Middle East & Africa Oral Vaccines Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Egypt Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South Africa Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Sales Channel: Direct Channel vs Indirect Channel

Figure 78. Methodology

Figure 79. Research Process and Data Source